Alcoholic steatohepatitis

Severe alcoholic steatohepatitis has a poor prognosis and is characterized by jaundice and signs of liver failure. Its incidence is unknown, but prevalence is around 20% in cohorts of alcoholics undergoing liver biopsy. Diagnosis is established with elevated liver transaminases, neutrophil counts, s...

Full description

Saved in:
Bibliographic Details
Main Authors: Stickel, Felix (Author) , Seitz, Helmut K. (Author)
Format: Article (Journal)
Language:English
Published: October 2010
In: Best practice & research. Clinical gastroenterology
Year: 2010, Volume: 24, Issue: 5, Pages: 683-693
ISSN:1532-1916
DOI:10.1016/j.bpg.2010.07.003
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bpg.2010.07.003
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S152169181000082X
Get full text
Author Notes:Felix Stickel, Helmut K. Seitz
Description
Summary:Severe alcoholic steatohepatitis has a poor prognosis and is characterized by jaundice and signs of liver failure. Its incidence is unknown, but prevalence is around 20% in cohorts of alcoholics undergoing liver biopsy. Diagnosis is established with elevated liver transaminases, neutrophil counts, serum bilirubin, and impaired coagulation and a history of excessive alcohol consumption, and exclusion of other etiologies. Histology is helpful but not mandatory. Prognostic scores include the Maddrey’s discriminant function, the model of end-stage liver disease, and the Glasgow Alcoholic Hepatitis Score. Pathophysiology involves hepatic fat storage, increased hepatic uptake of gut-derived endotoxins triggering Kupffer cell activation and release of proinflammatory triggers, induction of cytochrome P4502E1 producing toxic acetaldehyde and reactive oxygen species, and ethanol-mediated hyperhomocysteinemia causing endoplasmic reticulum stress. Treatment includes abstinence, enteral nutrition, corticosteroids, and possibly pentoxifylline. A debate is ongoing whether certain patients with severe alcoholic steatohepatitis could be eligible for liver transplantation.
Item Description:Gesehen am 01.12.2023
Physical Description:Online Resource
ISSN:1532-1916
DOI:10.1016/j.bpg.2010.07.003